Conference Coverage

Hospital-acquired pneumonia threatens cervical spinal cord injury patients


 

AT CSRS 2015

References

SAN DIEGO – The overall rate of hospital-acquired pneumonia following cervical spinal cord injury is about 20%, results from a study of national data demonstrated.

“Cervical spinal cord injury patients are at an increased risk for the development of hospital-acquired pneumonia,” lead study author Dr. Pablo J. Diaz-Collado said in an interview after the annual meeting of the Cervical Spine Research Society.

Dr. Pablo J. Diaz-Collado

Dr. Pablo J. Diaz-Collado

“Complete cord injuries, longer length of stay, ICU stay and ventilation time lead to significantly increased risk of HAP, which then leads to poor inpatient outcomes,” he said. “It is of crucial importance to keep these risk factors in mind when treating patients with cervical spinal cord injuries. There is a need to optimize the management protocols for these patients to help prevent the development of HAPs.”

Dr. Diaz-Collado, an orthopedic surgery resident at Yale–New Haven (Conn.) Hospital, and his associates identified 5,198 cervical spinal cord injury patients in the 2011 and 2012 National Trauma Data Bank (NTDB) to analyze risk factors for the development of HAP and inpatient outcomes in this population. They used multivariate logistic regression to identify independent associations of various risk factors with the occurrence of HAP.

The researchers found that the overall incidence of HAP among cervical spinal cord injury patients was 20.5%, which amounted to 1,065 patients. Factors independently associated with HAP were complete spinal cord injuries (compared to central cord injuries; OR 1.44; P = .009); longer inpatient length of stay (OR 3.08 for a stay that lasted 7-13 days, OR 10.21 for 21-27 days, and OR 14.89 for 35 days or more; P = .001 or less for all associations); longer ICU stay (OR 2.86 for a stay that lasted 9-11 days, OR 3.05 for 12-14 days, and OR 2.94 for 15 days or more; P less than .001 for all associations), and longer time on mechanical ventilation (OR 2.68 for ventilation that lasted 3-6 days, OR 3.76 for 7-13 days, OR 3.98 for 14-20 days, and OR 3.99 for 21 days or more; P less than .001 for all associations).

After the researchers controlled for all other risk factors, including patient comorbidities, Injury Severity Score, and other inpatient complications, HAP was associated with increased odds of death (OR 1.60; P = .005), inpatient adverse events (OR 1.65; P less than .001), discharge to an extended-care facility (OR 1.93; P = .001), and longer length of stay (a mean of an additional 10.93 days; P less than .001).

Dr. Diaz-Collado acknowledged that the study is “limited by the quality of the data entry. In addition, the database does not include classifications of fractures, and thus stratification of the analysis in terms of the different kinds of fractures in the cervical spine is not possible. Finally, procedural codes are less accurate and thus including whether or not patients underwent a surgical intervention is less reliable.”

Dr. Diaz-Collado reported having no financial disclosures.

dbrunk@frontlinemedcom.com

Recommended Reading

BRCA1 may have an impact in Alzheimer’s disease
MDedge Neurology
CTAD: Anti-tau vaccine demonstrated safety, immunogenicity in phase I study
MDedge Neurology
New analyses of data keep hope alive for Alzheimer’s drug gantenerumab
MDedge Neurology
GeneMatch designed to speed up Alzheimer’s trial recruitment
MDedge Neurology
Study characterizes injury risk in cervical myelopathy patients
MDedge Neurology
Detailed – not global – tests predict Alzheimer’s progression rates
MDedge Neurology
Second dose of herpes zoster vaccine beneficial to seniors
MDedge Neurology
More funding, new programs headline NIA’s 2015 Alzheimer’s report
MDedge Neurology
Have the conversation early: research proxies in Alzheimer’s disease
MDedge Neurology
Good luck convincing patients that generics equal brand-name drugs
MDedge Neurology